Fukushima Ryan’s July Insider Sale: 32,000 Tempus AI Shares Dumped at $56‑59

Insider Selling Continues to Shake Up TEMPUS AI

The latest Form 4 filing dated July 8, 2026 records a series of sales executed by the spouse of CEO and Data Officer Fukushima Ryan under a Rule 10b5‑1 plan. In total, 32 000 Class A shares were liquidated at a weighted‑average price ranging from $56.80 to $59.47, slightly below the market close of $61.50 on that day. After these transactions, Fukushima’s post‑transaction holdings were reduced to 167 763 shares, a significant drop from the over 600 000 shares held in May.

1. Contextualizing the Sale

• Magnitude versus market value – The dollar value of the sale exceeds $3 million, yet it represents a small fraction of TEMPUS AI’s market capitalization, which stood at $10.3 billion at the time.
• Timing – The sale occurred amid a broader pattern of insider divestitures that accelerated over the past two months. The CEO’s personal balance fell from roughly 600 000 shares in May to under 170 000 shares in early July.
• Price trajectory – The stock has traded down 4 % over the week, reflecting broader sell pressure that has also driven a 24 % spike in buzz and a positive sentiment score of +19.

While the transaction can be viewed as a routine execution of a pre‑approved plan, the rapid decline in holdings could signal insider sentiment that the stock is overvalued or that cash is required for other opportunities.

2. Fukushima Ryan’s Trading History

• Over the past year, the CEO has sold approximately 1.1 million shares in blocks of 10 000–15 000, maintaining a core holding of 150 000–200 000 shares since May.
• Notable past trades include a sale of 13 550 shares on May 19 at $44.07 and a purchase of 74 993 shares on February 20 recorded at $0.00, likely reflecting a block trade executed under a Rule 10b5‑1 plan at a later price.
• The pattern of buying back shares after a sale suggests a strategy of maintaining a strategic stake while freeing up liquidity.

3. Market Context

• Valuation – TEMPUS AI is a high‑growth healthcare AI firm listed on Nasdaq. Its 52‑week high is $104.32 and the low is $41.73.
• Profitability – The company’s P/E ratio is negative at –31.05, indicating that earnings have not yet met market expectations.
• Volatility – The stock’s price action has been volatile, and the recent insider sales are occurring in a high‑growth, high‑valuation environment.

4. Implications for Investors

• Insider behavior as a signal – Continued insider divestitures could be interpreted as a proactive cash‑management exercise or as an early indicator of a potential slowdown.
• Monitoring trends – Investors should track whether these sales are isolated or part of a broader sell‑off trend.
• Assessing confidence – The timing and volume of insider sales may provide a valuable data point in evaluating the company’s trajectory and the confidence its leadership places in the business.

5. Transaction Summary